Therefore, the strength of the observed associations between SOCS1 mutation subtypes and overall survival makes SOCS1 sequence analysis a promising prognostic biomarker candidate in DLBCL. This evidence concerns the gene SOCS1 and diffuse large B-cell lymphoma.